The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.
AMD is making a $20 million equity investment to bolster Absci's drug discovery efforts and expand AMDs accelerators and ROCm software.
President Trump revoked Joe Biden's 2023 order, which required HHS to establish an AI safety program and developers to share test results, among other directives.
The expansion includes prescribing capabilities and entry into the direct-to-consumer market.
Abu Mirza, GE HealthCare's global SVP of digital products and engineering, joined MobiHealthNews during JPM to discuss the company's efforts to leverage AI to improve care efficiency.
The app will allow patients to register digitally in less than 60 seconds and schedule appointments.
Also, Aevice Health from Singapore has obtained new investment for its global expansion.
The company will use the funds to accelerate development of its screening device.
Guardian's members with disabilities will receive an Uber voucher for medical appointments.
At an event outside JPM, which included a representative from HHS, panelists discussed the government's role in advancing AI and the evolving healthcare landscape as a new administration transitions into power.
